PMAQX
Price
$47.14
Change
-$0.52 (-1.09%)
Updated
Aug 1 closing price
Net Assets
32.26B
VMCCX
Price
$51.56
Change
-$0.27 (-0.52%)
Updated
Aug 1 closing price
Net Assets
2.71B
Interact to see
Advertisement

PMAQX vs VMCCX

Header iconPMAQX vs VMCCX Comparison
Open Charts PMAQX vs VMCCXBanner chart's image
Principal MidCap R6
Price$47.14
Change-$0.52 (-1.09%)
VolumeN/A
Net Assets32.26B
Virtus KAR Mid-Cap Core C
Price$51.56
Change-$0.27 (-0.52%)
VolumeN/A
Net Assets2.71B
PMAQX vs VMCCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
PMAQX vs. VMCCX commentary
Aug 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PMAQX is a Buy and VMCCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PMAQX has more cash in the bank: 32.3B vs. VMCCX (2.71B). PMAQX pays higher dividends than VMCCX: PMAQX (0.19) vs VMCCX (0.00). PMAQX was incepted earlier than VMCCX: PMAQX (9 years) vs VMCCX (16 years). VMCCX (2.04) is less costly to investors than PMAQX (0.59). VMCCX is a more actively managed with annual turnover of: 17.00 vs. PMAQX (10.50). PMAQX has a lower initial minimum investment than VMCCX: PMAQX (0) vs VMCCX (2500). PMAQX annual gain was more profitable for investors over the last year : 8.63 vs. VMCCX (3.37). PMAQX return over 5 years is better than : 51.81 vs. VMCCX (42.47).
PMAQXVMCCXPMAQX / VMCCX
Total Expense Ratio0.591.9530%
Annual Report Gross Expense Ratio0.592.0429%
Fund Existence9 years16 years-
Gain YTD5.6240.841669%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets32.3B2.71B1,194%
Annual Yield % from dividends0.190.00-
Returns for 1 year8.633.37256%
Returns for 3 years39.6220.78191%
Returns for 5 years51.8142.47122%
Returns for 10 yearsN/A135.97-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LYFCX11.840.13
+1.11%
AlphaCentric Life Sciences & Hlthcare C
NREEX13.54-0.02
-0.15%
Neuberger Berman Real Estate E
NIEYX17.81-0.08
-0.45%
BNY Mellon International Equity Y
LADCX9.94-0.14
-1.39%
Lord Abbett Developing Growth C
FVLKX13.58-0.24
-1.74%
Fidelity Value K